Nuix Launches Agentic AI in Nuix Neo with Audit Trail Built InPRNewsWire · 3 days ago
Nexalin Technology (NASDAQ:NXL) vs. IceCure Medical (NASDAQ:ICCM) Financial AnalysisDefense World · Oct 17, 2026
Nexalin Technology Regains Compliance with Nasdaq Minimum Bid Price Requirement; Nasdaq Hearings Panel Grants Request for Continued ListingGlobeNewsWire · Oct 8, 2026
Critical Survey: Enovis (NYSE:ENOV) vs. Nexalin Technology (NASDAQ:NXL)Defense World · Oct 6, 2026
Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue GenerationGlobeNewsWire · Oct 1, 2026
Nexalin Technology Taps Neuromodulation Commercial Executive Robert DiTota to Advise on its Global Commercialization StrategyGlobeNewsWire · Sep 29, 2026Nexalin Technology, Inc. operates as a medical device firm specializing in the creation and advancement of neurostimulation therapies for mental health conditions in both the United States and China. The company commercializes its primary product, the Nexalin Device, which provides a non-invasive and drug-free treatment for anxiety and insomnia. This device functions by emitting a proprietary frequency-based waveform designed to elicit a beneficial response from mid-brain structures associated with various psychological disorders.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 12, 2026 | -$3.00 | -$3.30 | Miss |
| May 8, 2026 | -$3.00 | -$0.11 | Beat |
| Mar 25, 2026 | -$0.12 | -$0.13 | Miss |
| Nov 14, 2025 | -$0.12 | -$0.13 | Miss |
| Aug 6, 2025 | -$0.10 | -$0.10 | Beat |
| May 13, 2025 | -$0.15 | -$0.15 | Beat |